Skip to the page

Data / Drug companies / Methocarbamol

Methocarbamol: 67 companies and 175 products in the FDA NDC directory

Methocarbamol is listed in the FDA National Drug Code Directory by 67 companies, with 175 products in commercial distribution. 171 of the products (97.7%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; tablet, film coated; injection, and the newest product started marketing on October 15, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
67
Products
175
Generic (ANDA) products
171 (97.7%)
Application numbers
20
Routes
Oral, Intravenous, Intramuscular
Brand names
Robaxin, Tanlor, Methocarb 500-Ezs, Atmeksi
openFDA record search
api.fda.gov

Companies that list methocarbamol

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
A-S Medication Solutions12tablet; tablet, film coatedGeneric drugs (ANDA)August 15, 2019
PD-Rx Pharmaceuticals, Inc.12tablet, film coated; tabletGeneric drugs (ANDA)June 10, 2025
Bryant Ranch Prepack10tablet; tablet, film coatedGeneric drugs (ANDA)May 22, 2025
Advanced Rx of Tennessee, LLC8tablet; tablet, film coatedGeneric drugs (ANDA)February 18, 2026
Bryant Ranch Prepack8tabletGeneric drugs (ANDA)January 1, 2021
Preferred Pharmaceuticals Inc.6tablet; tablet, film coatedGeneric drugs (ANDA)June 2, 2025
Aphena Pharma Solutions - Tennessee, LLC5tablet; tablet, film coatedGeneric drugs (ANDA)February 2, 2024
Asclemed USA, Inc.5tablet; tablet, film coatedGeneric drugs (ANDA)January 1, 2021
Bryant Ranch Prepack5tablet; tablet, film coatedGeneric drugs (ANDA)January 1, 2024
Asclemed USA Inc.4tablet; tablet, film coatedGeneric drugs (ANDA)May 22, 2025
Cardinal Health 107, LLC4tabletGeneric drugs (ANDA)March 25, 2020
Proficient Rx LP4tabletGeneric drugs (ANDA)May 22, 2025
Bostal LLC3tablet, coatedGeneric drugs (ANDA)July 16, 2022
Hawaii Repack, Inc.3tabletGeneric drugs (ANDA)January 1, 2021
Phoenix RX LLC3tablet; tablet, film coatedGeneric drugs (ANDA)May 22, 2025
Proficient Rx LP3tabletGeneric drugs (ANDA)March 20, 2013
Proficient Rx LP3tablet, film coated; tabletGeneric drugs (ANDA)January 15, 2018
St. Mary's Medical Park Pharmacy3tablet, film coated; tabletGeneric drugs (ANDA)September 17, 2026
American Health Packaging2tabletGeneric drugs (ANDA)May 20, 2020
Aurobindo Pharma Limited2tablet, film coatedGeneric drugs (ANDA)February 9, 2023
AvPAK2tabletGeneric drugs (ANDA)March 23, 2021
Camber Pharmaceuticals, Inc.2tabletGeneric drugs (ANDA)March 20, 2013
Coupler LLC2tabletGeneric drugs (ANDA)August 3, 2026
Direct RX2tablet; tablet, coatedGeneric drugs (ANDA)April 18, 2019
Direct_Rx2tabletGeneric drugs (ANDA)March 6, 2026
Doc Rx2tabletGeneric drugs (ANDA)May 22, 2025
Golden State Medical Supply, Inc.2tabletGeneric drugs (ANDA)January 1, 1982
Granulation Technology, Inc.2tablet, film coatedGeneric drugs (ANDA)June 10, 2025
Hikma Pharmaceuticals USA Inc.2injectionNew drug applications (NDA)October 17, 2017
Key Therapeutics2tabletGeneric drugs (ANDA)January 1, 2021
Major Pharmaceuticals2tabletGeneric drugs (ANDA)December 15, 2017
Marlex Pharmaceuticals, Inc.2tablet, film coatedGeneric drugs (ANDA)December 9, 2021
Medcore LLC2tablet, film coatedGeneric drugs (ANDA)July 31, 2026
NCS HealthCare of Ky, LLC DBA Vangard Labs2tablet, film coatedGeneric drugs (ANDA)February 9, 2023
Northwind Health Company, LLC2tabletGeneric drugs (ANDA)September 16, 2020
NuCare Pharmaceuticals, Inc.2tabletGeneric drugs (ANDA)March 20, 2013
NuCare Pharmaceuticals,Inc.2tablet, film coated; tabletGeneric drugs (ANDA)August 12, 2020
Oxford Pharmaceuticals, LLC2tabletGeneric drugs (ANDA)August 15, 2019
Redpharm Drug2tablet, film coated; tabletGeneric drugs (ANDA)February 9, 2023
Sagent Pharmaceuticals2injection, solutionGeneric drugs (ANDA)October 1, 2025
Solco Healthcare US, LLC2tabletGeneric drugs (ANDA)December 15, 2017
Unichem Pharmaceuticals (USA), Inc.2tablet, film coatedGeneric drugs (ANDA)January 15, 2018
XLCare Pharmaceuticals, Inc.2tabletGeneric drugs (ANDA)February 2, 2024
Aphena Pharma Solutions - Tennessee, LLC1tabletGeneric drugs (ANDA)August 15, 2019
Baxter Healthcare Corporation1injectionGeneric drugs (ANDA)July 14, 2022
Dr. Reddy's Laboratories Inc.1injectionGeneric drugs (ANDA)March 7, 2019
Eugia US LLC1injection, solutionGeneric drugs (ANDA)May 27, 2016
FH2 Pharma LLC1tablet, film coatedGeneric drugs (ANDA)August 30, 2024
Forte Bio-Pharma LLC1tablet, film coatedGeneric drugs (ANDA)August 30, 2024
Fresenius Kabi USA, LLC1injection, solutionGeneric drugs (ANDA)April 17, 2018
Gentex Pharma, LLC1tabletGeneric drugs (ANDA)May 22, 2025
Gland Pharma Limited1injectionGeneric drugs (ANDA)November 1, 2018
Henry Schein, Inc.1injection, solutionGeneric drugs (ANDA)April 6, 2023
Jvet Pharmaceuticals LLC1injectionGeneric drugs (ANDA)May 22, 2026
Medsource Pharmaceuticals1tabletGeneric drugs (ANDA)August 15, 2019
Meitheal Pharmaceuticals Inc.1injection, solutionGeneric drugs (ANDA)December 17, 2018
Misemer Pharmaceuticals, Inc.1tablet, coatedGeneric drugs (ANDA)September 13, 2022
Oncora Pharma, LLC1tablet, coatedGeneric drugs (ANDA)November 20, 2025
PureTek Corporation1kitOther unapproved drugsOctober 23, 2018
Regimed Medical1tabletGeneric drugs (ANDA)October 15, 2026
Remedyrepack Inc.1tabletGeneric drugs (ANDA)September 9, 2025
Rosemont Pharmaceuticals LLC1suspensionNew drug applications (NDA)December 22, 2025
Slate Run Pharmaceuticals, LLC1injectionGeneric drugs (ANDA)July 1, 2024
Somerset Therapeutics, LLC1injectionGeneric drugs (ANDA)July 31, 2017
Sportpharm LLC1tablet, film coatedGeneric drugs (ANDA)August 12, 2020
Trifluent Pharma, LLC1tablet, coatedGeneric drugs (ANDA)February 10, 2025
Unit Dose Solutions, Inc.1tabletGeneric drugs (ANDA)June 27, 2026

Dosage forms

Dosage formProductsShare
Tablet10459.4%
Tablet, film coated4726.9%
Injection84.6%
Tablet, coated84.6%
Injection, solution63.4%
Kit10.6%
Suspension10.6%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)17197.7%
New drug applications (NDA)31.7%
Other unapproved drugs10.6%

Pharmacologic classes

ClassProducts
Muscle Relaxant174

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.